Literature DB >> 28866270

Small molecule inhibitors of bacterial transcription complex formation.

Daniel S Wenholz1, Ming Zeng1, Cong Ma2, Marcin Mielczarek1, Xiao Yang2, Mohan Bhadbhade1, David St C Black1, Peter J Lewis3, Renate Griffith4, Naresh Kumar5.   

Abstract

Knoevenagel condensation was employed to generate a set of molecules potentially capable of inhibiting the RNA polymerase-σ70/σA interaction in bacteria. Synthesis was achieved via reactions between a variety of indole-7-carbaldehydes and rhodanine, N-allylrhodanine, barbituric acid or thiobarbituric acid. A library of structurally diverse compounds was examined by enzyme-linked immunosorbent assay (ELISA) to assess the inhibition of the targeted protein-protein interaction. Inhibition of bacterial growth was also evaluated using Bacillus subtilis and Escherichia coli cultures. The structure-activity relationship studies demonstrated the significance of particular structural features of the synthesized molecules for RNA polymerase-σ70/σA interaction inhibition and antibacterial activity. Docking was investigated as an in silico method for the further development of the compounds.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibacterial activity; Bacterial transcription; Indole; RNA polymerase; Structure-activity relationship (SAR)

Mesh:

Substances:

Year:  2017        PMID: 28866270     DOI: 10.1016/j.bmcl.2017.08.036

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  2 in total

Review 1.  RNA polymerases from low G+C gram-positive bacteria.

Authors:  Michael Miller; Aaron J Oakley; Peter J Lewis
Journal:  Transcription       Date:  2021-08-17

2.  Molecular Diversity via Tetrasubstituted Alkenes Containing a Barbiturate Motif: Synthesis and Biological Activity.

Authors:  Ahmed Al-Sheikh; Masuma Begum; Bian Zhang; Richard A Lewis; Nicholas E E Allenby; Paul G Waddell; Bernard T Golding
Journal:  Molecules       Date:  2020-12-11       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.